In this episode, Ben speaks with Gábor Somlyai, one of the earliest researchers to investigate the role of deuterium depletion in cancer biology.Gábor argues that while mainstream oncology has focused heavily on genes, mutations, and targeted drugs, a deeper regulatory layer may have been missed: the ratio between deuterium and hydrogen inside the body. He explains why he believes this matters for cell division, mitochondrial function, metabolic health, and cancer progression.The conversation covers the origins of his research, the early experiments that convinced him deuterium was influencing cell growth, and why he believes deuterium depletion should one day become part of standard oncology care.They also explore:why deuterium may matter at a sub-molecular levelhow mitochondria produce deuterium-depleted metabolic waterthe possible connection between ketogenic metabolism and lower deuterium stateswhy deuterium depleted water has become such a focus of his workhow he thinks about relapse prevention and long-term metabolic healththe potential implications beyond cancer, including diabetes, aging, and cognitionWhether you agree with the framework or are hearing about deuterium for the first time, this is a fascinating conversation about scientific paradigms, unconventional ideas, and the possibility that one missing variable could change how we think about disease.Exploring the benefits of red and infra light therapy? Our community receive 10% off via this linkWant to watch this on video? Subscribe on YouTubeInstagram @degreesofhealthDisclaimer Hosted on Acast. See acast.com/privacy for more information.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related